Clinical Web Archive

Sign in Subscribe

Neurology

Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial.

This data necessitates careful consideration of donanemab's clinical meaningfulness in early symptomatic Alzheimer disease, particularly regarding its modest effect on functional decline. 💡 Clinical Impact * Mechanistic Why: Donanemab targets and clears deposited amyloid plaques, a pathological hallmark of AD, demonstrating a direct biological intervention. * Clinical/Systemic Benefit: While demonstrating

rTMS Modulates Static and Dynamic Brain Functional Networks in Children with Autism Spectrum Disorder: An EEG Microstate Study.

Quick Take: rTMS shows a modulatory effect on brain functional networks in children with ASD, suggesting a potential therapeutic avenue requiring further validation. 💡 Clinical Impact * Mechanistic Why: This data necessitates understanding how rTMS impacts the dynamic and static functional connectivity within the autistic brain, particularly targeting network abnormalities implicated in

Functional Outcomes After Intensive Blood Pressure Reduction in Deep and Lobar Intracerebral Hemorrhage

Quick Take: In acute intracerebral hemorrhage (ICH), intensive early blood pressure lowering did not improve functional outcomes compared with standard treatment, suggesting that more aggressive BP targets should not be expected to improve recovery on their own. 💡 Clinical Impact Mechanistic Why: The rationale for intensive BP reduction in acute ICH

Immunosenescence and its impact on ischemic stroke risk and outcomes in older adults: a systematic review

Quick Take Immunosenescence—the progressive decline and dysregulation of the immune system—is a potent, independent driver of ischemic stroke risk and poor functional recovery. This shifts the view of stroke from a purely "plumbing" (vascular) issue to a systemic biological failure. 💡 Clinical Impact * The "Mechanistic Why&

Association between diabetes mellitus and risk of Alzheimer's disease: a meta-analysis and systematic review

Quick Take: Chronic hyperinsulinemia and glycemic volatility are potent drivers of neurodegeneration, establishing poorly controlled diabetes as a primary, modifiable risk factor for Alzheimer’s Disease (AD). 💡 Clinical Impact * Mechanistic Why: Systemic insulin resistance leads to cerebral insulin resistance, impairing the brain's primary energy metabolism. Furthermore, advanced glycation

The impact of bright light therapy on non-motor symptoms in patients with Parkinson's disease: a systematic review and meta-analysis

Quick Take: Bright light therapy (BLT) offers a robust, non-pharmacological signal for correcting the circadian disruptions that drive sleep and mood disturbances in Parkinson’s disease. 💡 Clinical Impact * Mechanistic Why: Parkinson’s involves significant circadian dysregulation due to the loss of dopaminergic neurons in the retina and the suprachiasmatic nucleus

Effect of robot-assisted training on cognitive function in post-stroke patients: a meta-analysis

Quick Take: This meta-analysis identifies a statistically significant signal for robot-assisted training as a potent catalyst for cognitive recovery in post-stroke rehabilitation. 💡 Clinical Impact * Mechanistic Why: Robot-assisted therapy provides high-dose, task-specific repetition coupled with precise biofeedback. This combination is thought to drive neuroplasticity by strengthening synaptic connections and facilitating the